Rixubis Lyophilisate For Solution For Injection 250U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

RIXUBIS: Lyophilisate for solution for injection (250U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

FACTOR IX (fak tir nine) is used in patients with hemophilia B to help control bleeding. Some products may also be used to control bleeding in patients with other disorders that prevent the blood from clotting properly.

In-Depth Information

RIXUBIS 250units Powder for Injection

NDC: 009443026
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Bleeding Prophylaxis

Sometimes used for but not FDA approved for the following conditions:
Surgical Bleeding, Hemarthrosis, Hemorrhage, Hemophilia B

Storage Information
May be stored at temperatures up to 86 degrees F for up to 6 months
Discard product if it contains particulate matter, is cloudy, or discolored
Discard unused portion. Do not store for later use.
Do not freeze
Store between 35 to 46 degrees F
Product stored at controlled room temperature should not be returned to a refrigerator
Reconstituted product should be used within 3 hours
RIXUBIS 250units Powder for Injection

Reported Side Effects for RIXUBIS 250units Powder for Injection

Antibody Formation Incidence:
3.0-16.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with RIXUBIS

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5